Erratum: GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF- β -Induced Smad3 Phosphorylation (J Am Soc Nephrol. (2015) 26: 8 (1827-1838) DOI: 10.1681/ASN.2014040363);GQ5 hinders renal fibrosis in obstructive nephropathy by selectively inhibiting TGF-β-induced Smad3 phosphorylation

Journal of the American Society of Nephrology

Volumn 26, Issue 8, 2015, Pages 1827-1838

  Ai, Jun ^a   Nie, Jing ^a   He, Jiangbo ^b   Guo, Qin ^a   Li, Mei ^a   Lei, Ying ^a   Liu, Youhua ^a   Zhou, Zhanmei ^a   Zhu, Fengxin ^a   Liang, Min ^a   Cheng, Yongxian ^b   Hou, Fan Fan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; GQ 5; PHENOL DERIVATIVE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; 3-(PENTADEC-8-ENYL)CATECHOL; CATECHOL DERIVATIVE; HERBACEOUS AGENT; MADH3 PROTEIN, RAT; SARA PROTEIN, RAT; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TGFB1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; RENAL PROTECTION; TOXICODENDRON VERNICIFLUUM; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; NEPHROSCLEROSIS; PHOSPHORYLATION; PHYTOTHERAPY; PRECLINICAL STUDY; RANDOMIZATION; RENAL INSUFFICIENCY, CHRONIC; SPRAGUE DAWLEY RAT; TOXICODENDRON;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CATECHOLS; CELL LINE; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; MALE; MICE, INBRED C57BL; NEPHROSCLEROSIS; PHOSPHORYLATION; PHYTOTHERAPY; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; SMAD3 PROTEIN; TOXICODENDRON; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84938936799     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.0000000000000307     Document Type: Erratum

References (54)

1. Zeisberg M, Neilson EG: Mechanisms of tubu-lointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834, 2010
2. Nangaku M: Mechanisms of tubulointerstitial in-juryinthe kidney: Final common pathwaystoend-stage renal failure. Intern Med 43: 9-17, 2004
3. Boor P, Ostendorf T, Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656, 2010
4. Liu Y: Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217, 2006
5. Schnaper HW, Hayashida T, Poncelet AC: It's a Smad world: Regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 13: 1126-1128, 2002
6. Böttinger EP, Bitzer M: TGF-beta signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002
7. Wang W, Koka V, Lan HY: Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 10: 48-56, 2005
8. Heldin CH, Miyazono K, ten Dijke P: TGF-beta signalling from cell membraneto nucleus through SMAD proteins. Nature 390: 465-471, 1997
9. Massagué J: TGF-beta signal transduction. Annu Rev Biochem 67: 753-791, 1998
10. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL: SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95: 779-791, 1998
11. Runyan CE, Schnaper HW, Poncelet AC: The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279: 2632-2639, 2004
12. Hu B, Wu Z, Phan SH: Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol 29: 397-404, 2003
13. Peinado H, Quintanilla M, Cano A: Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: Mechanisms for epithelialmesenchymal transitions. J Biol Chem 278: 21113-21123, 2003
14. Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB, Mauviel A: Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene 20: 3332-3340, 2001
15. Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, Mauviel A: SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci USA 95: 14769-14774, 1998
16. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J: Stim-ulationof type Icollagentranscriptionin humanskinfibroblasts by TGF-beta: Involvement of Smad 3. J Invest Dermatol 112: 49-57, 1999
17. Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, Yamamoto H, Bertram JF: Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 59: 2612-2624, 2010
18. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A: Targeted disruption of TGF-b1/Smad3 signaling protects against renal tubu-lointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494, 2003
19. Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura K, Kaneko K, Yamashiro Y, Ogawa H, Nakao A: Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 66: 597-604, 2004
20. Finer G, Schnaper HW, Kanwar YS, Liang X, Lin HY, Hayashida T: Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis. Kidney Int 82: 525-536, 2012
21. Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP, Lan HY: Smad2 protects against TGF-b/Smad3-mediated renal fibrosis. J Am Soc Nephrol 21: 1477-1487, 2010
22. Newman DJ, Cragg GM, Snader KM: Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037, 2003
23. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J: Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383: 832-836, 1996
24. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003
25. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875, 2002
26. Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK: IN-1130, a novel transforming growth factor-b type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 70: 1234-1243, 2006
27. Yang J, Liu Y: Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 284: F349-F357, 2003
28. Klein J, Gonzalez J, Duchene J, Esposito L, Pradère JP, Neau E, Delage C, Calise D, Ahluwalia A, Carayon P, Pesquero JB, Bader M, Schanstra JP, Bascands JL: Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J 23: 134-142, 2009
29. Leask A, Abraham DJ: TGF-b signaling and the fibrotic response. FASEB J 18: 816-827, 2004
30. Grande MT, López-Novoa JM: Fibroblast activation and myofibroblast generation inobstructive nephropathy. Nat Rev Nephrol 5: 319-328, 2009
31. Chevalier RL: Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol 13: 612-619, 1999
32. Sutaria PM, Ohebshalom M, McCaffrey TA, Vaughan ED Jr, Felsen D: Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci 62: 1965-1972, 1998
33. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993
34. Wei X, Xia Y, Li F, Tang Y, Nie J, Liu Y, Zhou Z, Zhang H, Hou FF: Kindlin-2 mediates activation of TGF-b/Smad signaling and renal fibrosis. J Am Soc Nephrol 24: 1387-1398, 2013
35. Jinnin M, Ihn H, Tamaki K: Characterization of SIS3, a novel specific in-hibitorofSmad3, and its effectontransforming growth factor-b1-induced extracellular matrix expression. Mol Pharmacol 69: 597-607, 2006
36. Tang Y, Katuri V, Dillner A, Mishra B, Deng CX, Mishra L: Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science 299: 574-577, 2003
37. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-b by the proteoglycan decorin. Nature 346: 281-284, 1990
38. Komesli S, Vivien D, Dutartre P: Chimeric extracellular domain type II transforming growth factor (TGF)-b receptor fused to the Fc region of human immunoglobulin as a TGF-b antagonist. Eur J Biochem 254: 505-513, 1998
39. Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu ZY, Green J, Anver MR, Merlino G, Wakefield LM: Lifetime exposure to a soluble TGF-b antagonist protects mice against metastasiswithout adverse sideeffects. J Clin Invest 109: 1607-1615, 2002
40. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
41. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC: Dysregulation of TGF-b activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407-411, 2003
42. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J: Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor b responses in skin fibroblasts. Arthritis Rheum 50: 4008-4021, 2004
43. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS: SB-431542 is a potent and specific inhibitor of transforming growth factor-b superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74, 2002
44. Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE: A novel small-molecule inhibitor of transforming growth factor b type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res 67: 2351-2359, 2007
45. ElSohly MA, Adawadkar PD, Ma CY, Turner CE: Separation and characterization of poison ivy and poison oak urushiol components. J Nat Prod 45: 532-538, 1982
46. Yang M, He JB, Cheng YX, Jiang S: Synthesis of 3-[(Z)-Pentadec-8-enyl] catechol and its anti-angiogenesis activity. Chin J Org Chem 33: 1319-1325, 2013
47. Yang J, Dai C, Liu Y: Hepatocyte growth factor gene therapy and an-giotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13: 2464-2477, 2002
48. Wang L, Lyerla T: Histochemical and cellular changes accompanying the appearance of lung fibrosis in an experimental mouse model for Hermansky Pudlak syndrome. Histochem Cell Biol 134: 205-213, 2010
49. Zhang H, Berg JS, Li Z, Wang Y, Lång P, Sousa AD, Bhaskar A, Cheney RE, Strömblad S: Myosin-X provides a motor-based link between in-tegrins and the cytoskeleton. Nat Cell Biol 6: 523-531, 2004
50. Yoo KH, Thornhill BA, Forbes MS, Coleman CM, Marcinko ES, Liaw L, Chevalier RL: Osteopontin regulates renal apoptosis and interstitial fi-brosis in neonatal chronic unilateral ureteral obstruction. Kidney Int 70: 1735-1741, 2006
51. Hao S, Shen H, Hou Y, Mars WM, Liu Y: tPA is a potent mitogen for renal interstitial fibroblasts: Role of beta1 integrin/focal adhesion kinase signaling. Am J Pathol 177: 1164-1175, 2010
52. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY: Smad7 inhibits fibrotic effect of TGF-b on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13: 1464-1472, 2002
53. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ: Inhibition ofrenal fibrosisby genetransferofinducibleSmad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14: 1535-1548, 2003
54. Fritschy JM, Benke D, Mertens S, Oertel WH, Bachi T, Möhler H: Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with sub-unit-specific antibodies. Proc Natl Acad Sci USA 89: 6726-6730, 1992